Envveno Medical Corp (NVNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,597 | 3,065 | 1,544 | 2,044 | 2,937 |
| Marketable Securities | 22,333 | 25,147 | 29,408 | 33,098 | 36,004 |
| TOTAL | $25,489 | $28,826 | $31,499 | $35,604 | $39,479 |
| Non-Current Assets | |||||
| PPE Net | 16 | 51 | 82 | 113 | 142 |
| Other Non-Current Assets | 592 | 685 | 771 | 860 | 956 |
| TOTAL | $608 | $736 | $853 | $973 | $1,098 |
| Total Assets | $26,097 | $29,562 | $32,352 | $36,577 | $40,577 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,747 | 1,732 | 2,114 | 2,638 | 1,291 |
| TOTAL | $2,143 | $2,122 | $2,400 | $3,015 | $1,661 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 207 | 310 | 505 | 505 | 609 |
| TOTAL | $207 | $310 | $505 | $505 | $609 |
| Total Liabilities | $2,350 | $2,432 | $2,905 | $3,520 | $2,270 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 668 | 656 | 576 | 549 | 500 |
| Retained earnings | -175,176 | -171,327 | -167,591 | -163,052 | -156,358 |
| TOTAL | $23,747 | $27,130 | $29,447 | $33,057 | $38,307 |
| Total Liabilities And Equity | $26,097 | $29,562 | $32,352 | $36,577 | $40,577 |